UNSPSC 51111642: Irinotecan

This classification denotes a camptothecin analogue with the molecular formula C33H38N4O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7673326042, chemically known as irinotecan, cpt-11 but generally known as irinotecan, which bears US NIH Compound Identifier 60838. European Medicines Agency schedules Irinotecan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08295MIG.

UNSPSC 51111642 Irinotecan is a Commodity code covering the procurement of a specific chemotherapy agent used in cancer treatment. State and local governments acquire irinotecan primarily through health and human services agencies, particularly state Medicaid programs and correctional health systems that serve incarcerated populations requiring oncology care. Procurement under this code reflects the purchasing patterns of state pharmacy benefit programs, which source branded and generic formulations to support covered beneficiaries across outpatient and inpatient settings. The issuing bodies are predominantly state health and human services departments managing pharmacy benefits and drug formularies, with secondary activity from state correctional agencies and regional health authorities operating formulary-restricted drug acquisition programs.

The Texas Health and Human Services Commission issued a Request for Information (RFI No. HHS0017013) posted April 3, 2026, to gather vendor capabilities regarding direct-to-manufacturer prescription programs and alternative contracting models for pharmaceutical procurement outside traditional pharmacy benefit manager and group purchasing organization channels. The RFI seeks information from vendors on direct contracting experience with self-insured employers and government health plans, negotiated net pricing models, and outcomes-based agreement structures. This exploratory procurement signals the state's intent to reshape its drug acquisition strategy before issuing formal solicitations. The geographic activity under this code is concentrated in states with large Medicaid populations and mature state employee health benefit programs, though the source material identifies Texas as the primary recent jurisdiction with active procurement activity.